Literature DB >> 21680900

Role of Jagged1 in arterial lesions after vascular injury.

Xiaojing Wu1, Yunzeng Zou, Qi Zhou, Lan Huang, Hui Gong, Aijun Sun, Kaoru Tateno, Ken-ichi Katsube, Freddy Radtke, Junbo Ge, Tohru Minamino, Issei Komuro.   

Abstract

OBJECTIVE: Impaired regeneration of endothelial cells (EC) and overactivity of vascular smooth muscle cells (VSMC) are hallmarks of the arterial lesions associated with aging. The occurrence of 2 opposing cellular processes in the same arterial milieu makes pharmaceutical treatment difficult to develop. We previously reported that endothelial expression of a Notch ligand (Jagged1) was reduced in aged animals and that growth of the neointima was enhanced in these animals. METHODS AND
RESULTS: Similar to aged animals, Tie2-cre(+) Jagged1(lox/+) mice (with heterologous knockout of Jagged1 in EC) showed exaggerated intimal and medial thickening after carotid artery ligation. Unexpectedly, these mice showed little increase of Jagged1 expression not only in EC but also in VSMC, in contrast to a significant upregulation of Jagged1 in wild-type arteries after ligation. Coculture of VSMC with Jagged1-null EC resulted in the transition of VSMC from the contractile to the synthetic phenotype, along with decreased Jagged1 expression by VSMC. Conversely, overexpression of Jagged1 by EC or VSMC was shown to prevent the unfavorable phenotypic transition of VSMC, under both monoculture and coculture conditions.
CONCLUSIONS: These findings suggest a unidirectional effect of Jagged1 on both EC and VSMC that contributes to inhibition of arterial lesions after vascular injury. Our data also indicate that Jagged1 may be a novel therapeutic target for aging-related vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680900     DOI: 10.1161/ATVBAHA.111.225144

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

1.  Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling.

Authors:  Fatima Z Saddouk; Li-Yan Sun; Yong Feng Liu; Miao Jiang; Diane V Singer; Johannes Backs; Dee Van Riper; Roman Ginnan; John J Schwarz; Harold A Singer
Journal:  FASEB J       Date:  2015-11-13       Impact factor: 5.191

Review 2.  Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.

Authors:  Eileen M Redmond; Shaunta Guha; Dermot Walls; Paul A Cahill
Journal:  Expert Opin Investig Drugs       Date:  2011-10-18       Impact factor: 6.206

3.  The Notch pathway attenuates interleukin 1β (IL1β)-mediated induction of adenylyl cyclase 8 (AC8) expression during vascular smooth muscle cell (VSMC) trans-differentiation.

Authors:  Zela Keuylian; Jeroen H F de Baaij; Marie Gueguen; Martine Glorian; Clotilde Rouxel; Elise Merlet; Larissa Lipskaia; Régis Blaise; Véronique Mateo; Isabelle Limon
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

4.  Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.

Authors:  Dario F Riascos-Bernal; Prameladevi Chinnasamy; Jordana N Gross; Vanessa Almonte; Lander Egaña-Gorroño; Dippal Parikh; Smitha Jayakumar; Liang Guo; Nicholas E S Sibinga
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-16       Impact factor: 8.311

5.  A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B.

Authors:  Joshua M Boucher; Anne Harrington; Bahman Rostama; Volkhard Lindner; Lucy Liaw
Journal:  Circ Res       Date:  2013-08-21       Impact factor: 17.367

6.  AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.

Authors:  Ujala Rana; Emily Callan; Brianna Entringer; Teresa Michalkiewicz; Amit Joshi; Abdul K Parchur; Ru-Jeng Teng; Girija G Konduri
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

Review 7.  The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors.

Authors:  Paola Rizzo; Donato Mele; Cristiana Caliceti; Micaela Pannella; Cinzia Fortini; Anthony George Clementz; Marco Bruno Morelli; Giorgio Aquila; Pietro Ameri; Roberto Ferrari
Journal:  Front Oncol       Date:  2015-01-13       Impact factor: 6.244

8.  Phospholipase Cγ1 Mediates Intima Formation Through Akt-Notch1 Signaling Independent of the Phospholipase Activity.

Authors:  Dongyang Jiang; Jianhui Zhuang; Wenhui Peng; Yuyan Lu; Hao Liu; Qian Zhao; Chen Chi; Xiankai Li; Guofu Zhu; Xiangbin Xu; Chen Yan; Yawei Xu; Junbo Ge; Jinjiang Pang
Journal:  J Am Heart Assoc       Date:  2017-07-11       Impact factor: 5.501

9.  Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation.

Authors:  Sarah M Peterson; Jacqueline E Turner; Anne Harrington; Jessica Davis-Knowlton; Volkhard Lindner; Thomas Gridley; Calvin P H Vary; Lucy Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-31       Impact factor: 8.311

10.  Role of IGFBP1 in the senescence of vascular endothelial cells and severity of aging‑related coronary atherosclerosis.

Authors:  Xiaojing Wu; Wei Zheng; Peng Jin; Junhao Hu; Qi Zhou
Journal:  Int J Mol Med       Date:  2019-09-12       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.